Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to $964000.0.

  • Lyra Therapeutics' Prepaid Assets fell 6579.13% to $964000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $964000.0, marking a year-over-year decrease of 6579.13%. This contributed to the annual value of $2.4 million for FY2024, which is 1837.52% up from last year.
  • Per Lyra Therapeutics' latest filing, its Prepaid Assets stood at $964000.0 for Q3 2025, which was down 6579.13% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Lyra Therapeutics' Prepaid Assets peaked at $2.9 million during Q4 2022, and registered a low of $964000.0 during Q3 2025.
  • For the 5-year period, Lyra Therapeutics' Prepaid Assets averaged around $2.0 million, with its median value being $2.1 million (2023).
  • As far as peak fluctuations go, Lyra Therapeutics' Prepaid Assets surged by 4446.23% in 2022, and later crashed by 6579.13% in 2025.
  • Quarter analysis of 5 years shows Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then skyrocketed by 35.19% to $2.9 million in 2022, then decreased by 29.54% to $2.1 million in 2023, then increased by 18.38% to $2.4 million in 2024, then plummeted by 60.62% to $964000.0 in 2025.
  • Its last three reported values are $964000.0 in Q3 2025, $1.3 million for Q2 2025, and $2.2 million during Q1 2025.